WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1996005200) TETRAHYDROPYRIDINYLMETHYL DERIVATIVES OF PYRROLO[2,3-b]PYRIDINE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1996/005200    International Application No.:    PCT/GB1995/001820
Publication Date: 22.02.1996 International Filing Date: 01.08.1995
Chapter 2 Demand Filed:    17.01.1996    
IPC:
C07D 471/04 (2006.01)
Applicants: MERCK SHARP & DOHME LIMITED [GB/GB]; Hertford Road, Hoddesdon, Hertfordshire EN11 9BU (GB) (For All Designated States Except US).
CURTIS, Neil, Roy [GB/GB]; (GB) (For US Only).
KULAGOWSKI, Janusz, Jozef [GB/GB]; (GB) (For US Only).
LEESON, Paul, David [GB/US]; (GB) (For US Only).
RIDGILL, Mark, Peter [GB/GB]; (GB) (For US Only)
Inventors: CURTIS, Neil, Roy; (GB).
KULAGOWSKI, Janusz, Jozef; (GB).
LEESON, Paul, David; (GB).
RIDGILL, Mark, Peter; (GB)
Agent: THOMPSON, John; Merck & Co., Inc., European Patent Dept., Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR (GB)
Priority Data:
9416160.1 10.08.1994 GB
9416161.9 10.08.1994 GB
9505888.9 23.03.1995 GB
Title (EN) TETRAHYDROPYRIDINYLMETHYL DERIVATIVES OF PYRROLO[2,3-b]PYRIDINE
(FR) DERIVES TETRAHYDROPYRIDINYLMETHYLE DE PYRROLO[2,3-b]PYRIDINE
Abstract: front page image
(EN)A class of pyrrolo[2,3-b]pyridine derivatives of formula (I), wherein Q represents a moiety of formula Qa or Qb, are ligands for dopamine receptor subtypes within the body, in particular the dopamine D¿4? receptor subtype and are therefore useful in the treatment and/or prevention of disorders of the dopamine system, including schizophrenia.
(FR)Classe de dérivés de pyrrolo[2,3-b]pyridine, de la formule (I), dans laquelle Q représente une fraction de formule Qa ou Qb. Ces dérivés sont des ligands de sous-types de récepteurs de la dopamine dans le corps, notamment du sous-type de récepteur D¿4? de la dopamine, et ils sont par conséquent utiles dans le traitement et/ou la prévention de troubles du système dopamine, notamment de la schizophrénie.
Designated States: AM, AT, AU, BB, BG, BR, BY, CA, CH, CN, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IS, JP, KE, KG, KP, KR, KZ, LK, LR, LT, LU, LV, MD, MG, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TT, UA, UG, US, UZ, VN.
African Regional Intellectual Property Organization (KE, MW, SD, SZ, UG)
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)